Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathé

Showing results (521-530 of 550) with videos related to

Pageof 55
Sort By:
The Prostate|January 1, 1986
Phase II trial with D-Trp-6-LH-RH in prostatic carcinoma: comparison with other hormonal agentsG Mathé, A V Schally, A M Comaru-Schally, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Results of a randomized trial of prophylactic chemotherapy in T3-T4 breast cancer patients previously treated by radiotherapyB Serrou, H Sancho-Garnier, P Cappelaere, et al.
La Nouvelle Presse Medicale|December 20, 1975
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV]J L Misset, P Pouillart, J L Amiel, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Phase II trial of aclacinomycin in acute leukemia and lymphosarcomaG Mathé, M A Gil, M Delgado, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trialM Hayat, G Brulé, P Cappelaere, et al.
La Nouvelle Presse Medicale|February 23, 1974
[Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)]G Mathé, L Schwarzenberg, P Pouillart, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1975
Immunoblastic lymphosarcoma, a cytological and clinical entity?G Mathé, D Belpomme, D Dantchev, et al.
Anticancer Research|January 1, 1982
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trialJ L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon]J L Misset, G Mathé, J Gastiaburu, et al.
La Nouvelle Presse Medicale|March 2, 1974
[Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)]G Mathé, L Schwarzenberg, P Pouillart, et al.
Pageof 55

Showing results (521-530 of 550) with videos related to

Sort By:
Pageof 55
The Prostate|January 1, 1986
Phase II trial with D-Trp-6-LH-RH in prostatic carcinoma: comparison with other hormonal agentsG Mathé, A V Schally, A M Comaru-Schally, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Results of a randomized trial of prophylactic chemotherapy in T3-T4 breast cancer patients previously treated by radiotherapyB Serrou, H Sancho-Garnier, P Cappelaere, et al.
La Nouvelle Presse Medicale|December 20, 1975
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV]J L Misset, P Pouillart, J L Amiel, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Phase II trial of aclacinomycin in acute leukemia and lymphosarcomaG Mathé, M A Gil, M Delgado, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trialM Hayat, G Brulé, P Cappelaere, et al.
La Nouvelle Presse Medicale|February 23, 1974
[Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)]G Mathé, L Schwarzenberg, P Pouillart, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1975
Immunoblastic lymphosarcoma, a cytological and clinical entity?G Mathé, D Belpomme, D Dantchev, et al.
Anticancer Research|January 1, 1982
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trialJ L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon]J L Misset, G Mathé, J Gastiaburu, et al.
La Nouvelle Presse Medicale|March 2, 1974
[Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)]G Mathé, L Schwarzenberg, P Pouillart, et al.
Pageof 55